Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
2.490
+0.050 (2.05%)
At close: Jul 26, 2024, 4:00 PM
2.380
-0.110 (-4.42%)
After-hours: Jul 26, 2024, 7:09 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $224.89 million as of July 26, 2024. Its market cap has decreased by -52.77% in one year.
Market Cap
224.89M
Enterprise Value
-45.55M
1-Year Change
-52.77%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $224.89M, a decrease of -74.69%. That is a compound annual growth rate of -36.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 220.40M | -56.50% |
| Dec 29, 2023 | 506.70M | 32.26% |
| Dec 30, 2022 | 383.10M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Joint | 210.16M |
| Greenwich LifeSciences | 209.94M |
| Abeona Therapeutics | 209.52M |
| P3 Health Partners | 209.41M |
| Molecular Partners AG | 209.38M |
| Inhibrx | 208.31M |
| ClearPoint Neuro | 207.02M |
| Ventyx Biosciences | 204.10M |